{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T19:25:49Z","timestamp":1789068349457,"version":"build-2803163510"},"reference-count":27,"publisher":"Impact Journals, LLC","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,3,22]]},"DOI":"10.18632\/oncotarget.6948","type":"journal-article","created":{"date-parts":[[2016,1,19]],"date-time":"2016-01-19T16:35:42Z","timestamp":1453221342000},"page":"13551-13562","source":"Crossref","is-referenced-by-count":23,"title":["Low expression of CD200 predicts shorter time-to-treatment in chronic lymphocytic leukemia"],"prefix":"10.18632","volume":"7","author":[{"given":"Yi","family":"Miao","sequence":"first","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing 210029, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Fan","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing 210029, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Jie","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing 210029, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Xia","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing 210029, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Qiao","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing 210029, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing 210029, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing 210029, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Hong","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing 210029, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua-Yuan","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing 210029, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing 210029, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Yong","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing 210029, China"},{"name":"Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing 210029, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,1,19]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1001\/jama.2014.14553","article-title":"Chronic lymphocytic leukemia: a clinical review","volume":"312","author":"Rosen","year":"2014","journal-title":"Jama"},{"key":"2","first-page":"391","article-title":"Chronic lymphocytic leukemia: novel prognostic factors and their relevance for risk-adapted therapeutic strategies","volume":"90","author":"Morra","year":"2005","journal-title":"Haematologica"},{"key":"3","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1182\/blood.V94.6.1840","article-title":"Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia","volume":"94","author":"Vinciguerra","year":"1999","journal-title":"Blood"},{"key":"4","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1056\/NEJMoa023143","article-title":"ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia","volume":"348","author":"Montserrat","year":"2003","journal-title":"The New England journal of medicine"},{"key":"5","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S1471-4906(02)02223-8","article-title":"CD200 and membrane protein interactions in the control of myeloid cells","volume":"23","author":"Brown","year":"2002","journal-title":"Trends Immunol"},{"key":"6","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1182\/blood-2006-06-029355","article-title":"CD200 is a new prognostic factor in multiple myeloma","volume":"108","author":"Rossi","year":"2006","journal-title":"Blood"},{"key":"7","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.leukres.2009.01.017","article-title":"CD200 expression may help in differential diagnosis between mantle cell lymphoma and B-cell chronic lymphocytic leukemia","volume":"33","author":"Di Raimondo","year":"2009","journal-title":"Leukemia research"},{"key":"8","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/cytob.21128","article-title":"CD200 has an important role in the differential diagnosis of mature B-cell neoplasms by multiparameter flow cytometry","volume":"86","author":"Rizzatti","year":"2014","journal-title":"Cytometry Part B, Clinical cytometry"},{"key":"9","first-page":"1","article-title":"Expression patterns of CD200 and CD148 in leukemic B-cell chronic lymphoproliferative disorders and their potential value in differential diagnosis","author":"Li","year":"2015","journal-title":"Leukemia & lymphoma"},{"key":"10","doi-asserted-by":"crossref","first-page":"56","DOI":"10.2310\/JIM.0b013e31823908f9","article-title":"CD200 expression in B-cell chronic lymphoproliferative disorders","volume":"60","author":"Mohammed","year":"2012","journal-title":"Journal of investigative medicine"},{"key":"11","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1365-2141.2009.07644.x","article-title":"CD200\/OX2, a cell surface molecule with immuno-regulatory function, is consistently expressed on hairy cell leukaemia neoplastic cells","volume":"145","author":"Del Vecchio","year":"2009","journal-title":"British journal of haematology"},{"key":"12","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1309\/AJCPBV9ELXC0ECVL","article-title":"Differential expression of CD200 in B-cell neoplasms by flow cytometry can assist in diagnosis, subclassification, and bone marrow staging","volume":"142","author":"Jorgensen","year":"2014","journal-title":"American journal of clinical pathology"},{"key":"13","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1073\/pnas.0510081103","article-title":"Antibodies selected from combinatorial libraries block a tumor antigen that plays a key role in immunomodulation","volume":"103","author":"Bowdish","year":"2006","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"14","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s00277-010-1125-8","article-title":"The prognostic significance of TP53 mutations in Chinese patients with chronic lymphocytic leukemia is independent of del (17p13)","volume":"90","author":"Li","year":"2011","journal-title":"Annals of hematology"},{"key":"15","doi-asserted-by":"publisher","first-page":"5426","DOI":"10.18632\/oncotarget.3101","article-title":"Frequencies of SF3B1, NOTCH1, MYD88, BIRC3 and IGHV mutations and TP53 disruptions in Chinese with chronic lymphocytic leukemia: disparities with Europeans","volume":"6","author":"Li","year":"2015","journal-title":"Oncotarget"},{"key":"16","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1189\/jlb.1009686","article-title":"The role of CD200 in immunity to B cell lymphoma","volume":"88","author":"Gorczynski","year":"2010","journal-title":"Journal of leukocyte biology"},{"key":"17","doi-asserted-by":"crossref","first-page":"3790","DOI":"10.1182\/blood-2013-12-543306","article-title":"Mutations in TLR\/MYD88 pathway identify a subset of young chronic lymphocytic leukemia patients with favorable outcome","volume":"123","author":"Colado","year":"2014","journal-title":"Blood"},{"key":"18","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1172\/JCI24176","article-title":"Chronic lymphocytic leukemia cells induce changes in gene expression of CD4 and CD8 T cells","volume":"115","author":"Gribben","year":"2005","journal-title":"The Journal of clinical investigation"},{"key":"19","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.leukres.2008.08.021","article-title":"Disruption of T cell suppression in chronic lymphocytic leukemia by CD200 blockade","volume":"33","author":"Wendtner","year":"2009","journal-title":"Leukemia research"},{"key":"20","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1309\/AJCP59UORCYZEVQO","article-title":"Diagnostic usefulness and prognostic impact of CD200 expression in lymphoid malignancies and plasma cell myeloma","volume":"137","author":"Lorsbach","year":"2012","journal-title":"American journal of clinical pathology"},{"key":"21","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1136\/jclinpath-2014-202421","article-title":"Diagnostic and prognostic significance of CD200 expression and its stability in plasma cell myeloma","volume":"67","author":"Li","year":"2014","journal-title":"Journal of clinical pathology"},{"key":"22","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/sj.leu.2404559","article-title":"CD200 as a prognostic factor in acute myeloid leukaemia","volume":"21","author":"Darley","year":"2007","journal-title":"Leukemia"},{"key":"23","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, inflammation, and cancer","volume":"140","author":"Karin","year":"2010","journal-title":"Cell"},{"key":"24","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.leukres.2013.04.014","article-title":"Ectodomain shedding of CD200 from the B-CLL cell surface is regulated by ADAM28 expression","volume":"37","author":"Gorczynski","year":"2013","journal-title":"Leukemia research"},{"key":"25","doi-asserted-by":"crossref","first-page":"5446","DOI":"10.1182\/blood-2007-06-093906","article-title":"Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines","volume":"111","author":"Kipps","year":"2008","journal-title":"Blood"},{"key":"26","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.leukres.2007.10.009","article-title":"Prognostic significance of ATM, TP53 deletions in Chinese patients with chronic lymphocytic leukemia","volume":"32","author":"Qiu","year":"2008","journal-title":"Leukemia research"},{"key":"27","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1182\/blood.V99.3.1023","article-title":"CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease","volume":"99","author":"Oscier","year":"2002","journal-title":"Blood"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.6948","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T18:00:50Z","timestamp":1589220050000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.6948"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,19]]},"references-count":27,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,3,22]]}},"alternative-id":["6948","26910908"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.6948","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,19]]}}}